$Protagonist Therapeutics, Inc. Common Stock(PTGX)$ 8-K - Current report Filed: 2017-05-10 AccNo: 0001193125-17-165849 Size: 59 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接